Search results
Results from the WOW.Com Content Network
Normal cervical cells in a Pap smear. In the conventional Pap smear, the collected cells are smeared on a microscope slide, and a fixative is applied. The slide is evaluated in a pathology lab to identify cellular abnormalities. Accuracy of conventional cytology report: [10] sensitivity: 55% to 88%; specificity: 71% to 94%
The Papanicolaou test (abbreviated as Pap test, also known as Pap smear (AE), [1] cervical smear (BE), cervical screening (BE), [2] or smear test (BE)) is a method of cervical screening used to detect potentially precancerous and cancerous processes in the cervix (opening of the uterus or womb) or, more rarely, anus (in both men and women). [3]
The task force has introduced a recommendation that women over the age of 30 test for high-risk human papilloma viruses (HPV) every five years rather than relying on pap smears to detect cervical ...
Papanicolaou stain (also Papanicolaou's stain and Pap stain) is a multichromatic (multicolored) cytological staining technique developed by George Papanicolaou in 1942. [ 1 ] [ 2 ] [ 3 ] The Papanicolaou stain is one of the most widely used stains in cytology , [ 1 ] where it is used to aid pathologists in making a diagnosis.
According to Dr. Harrison, “Women should stop having cervical cancer screening after age 65 if they do not have a history of abnormal cervical cells or cervical cancer, and they have had either ...
Depending on patient's age or Pap smear result, HPV testing may also be performed. Sexually transmitted infection screening - Depending on age and risk factors, clinicians may recommend gonorrhea or chlamydia testing at the time of the well-woman exam. This sample can be collected via a swab of the cervix or vagina.
Pap test screening can reveal abnormal cells on the surface of the cervix called cervical intraepithelial neoplasia (CIN) which in a small percentage can develop into cervical cancer. These precancerous changes can be confirmed with further examination known as colposcopy .
The Bethesda system (TBS), officially called The Bethesda System for Reporting Cervical Cytology, is a system for reporting cervical or vaginal cytologic diagnoses, [1] used for reporting Pap smear results. It was introduced in 1988 [2] and revised in 1991, [3] 2001, [1] [4] [5] and 2014. [6]